V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 210033297 | 210011546 | 0 | 46.1 | Curative (C) | 2017-11-21 | 2018-02-21 | ALL UKALL2003 TRIAL | 02 | null | 210030013 | UKALL 2003 |
| 210033298 | 210011548 | null | 27.75 | Curative (C) | 2016-03-23 | 2016-03-23 | IDELALISIB + RITUXIMAB | N | null | 210030014 | IDELALISIB + RITUXIMAB |
| 210033299 | 210011560 | 1.65 | null | Curative (C) | null | 2017-06-21 | METHOTREXATE | N | N | 210030095 | METHOTREXATE |
| 210033300 | 210011568 | 1.29 | null | Disease modification (D) | 2016-09-06 | 2016-12-27 | CHLORAMBUCIL + OBINUTUZUMAB | Y | N | 210030141 | CHLORAMBUCIL + OBINUTUZUMAB |
| 210033301 | 210011578 | 1.62 | 65.5 | Palliative (P) | 2017-09-22 | 2017-10-03 | Triple / Double Intrathecal Therapy | N | N | 210030161 | TRIPLE INTRATHECAL |
| 210033302 | 210011581 | null | 80.7 | Disease modification (D) | 2019-04-02 | 2019-04-30 | Chlorambucil + Pred + Rituximab | N | N | 210030163 | CHLORAMBUCIL + RITUXIMAB |
| 210033303 | 210011585 | null | 65.15 | Curative (C) | 2017-04-29 | 2017-07-02 | Imatinib 400mg | N | N | 210030165 | IMATINIB |
| 210033304 | 210011587 | -1 | 63 | Curative (C) | 2015-08-19 | 2016-01-07 | CHLORAMBUCIL + OBINUTUZUMAB | null | null | 210030175 | CHLORAMBUCIL + OBINUTUZUMAB |
| 210033305 | 210011590 | null | 73.9 | Curative (C) | 2014-09-23 | 2014-09-23 | CHLORAMBUCIL + OBINUTUZUMAB | N | N | 210030184 | CHLORAMBUCIL + OBINUTUZUMAB |
| 210033306 | 210011591 | 0 | 62.7 | Curative (C) | null | 2018-09-23 | CHLORAMBUCIL + RITUXIMAB | Y | N | 210030192 | CHLORAMBUCIL + RITUXIMAB |
| 210033308 | 210011637 | null | 68.8 | Curative (C) | 2017-02-09 | 2017-03-02 | ALL UKALL60+ TRIAL | N | null | 210030435 | UKALL60+ |
| 210033309 | 210011662 | 1.82 | 74.7 | Curative (C) | 2016-01-24 | 2016-01-24 | METHOTREXATE | 99 | N | 210030563 | METHOTREXATE |
| 210033310 | 210031155 | 1.6 | 76.4 | Curative (C) | 2017-11-16 | 2018-01-30 | METHOTREXATE | N | N | 210030604 | METHOTREXATE |
| 210033311 | 210011673 | null | null | Curative (C) | 2015-11-06 | 2016-01-20 | ALL UKALL2003 TRIAL | N | null | 210030624 | UKALL 2003 |
| 210033312 | 210011724 | 1.63 | 95.3 | Disease modification (D) | null | 2017-05-04 | CHLORAMBUCIL + OBINUTUZUMAB | 2 | N | 210031008 | CHLORAMBUCIL + OBINUTUZUMAB |
| 210033313 | 210011731 | 1.74 | 74.4 | Curative (C) | 2016-02-15 | 2016-03-05 | IDELALISIB + RITUXIMAB | N | N | 210031025 | IDELALISIB + RITUXIMAB |
| 210033314 | 210011766 | 1.7 | 83.2 | Curative (C) | 2016-01-11 | 2016-04-04 | ALL UKALL60+ TRIAL | 2 | N | 210031164 | UKALL60+ |
| 210033315 | 210021523 | 0 | 83.3 | Disease modification (D) | 2018-11-11 | 2018-11-11 | IMATINIB | N | N | 210031354 | IMATINIB |
| 210033316 | 210011814 | 0 | null | null | 2017-03-04 | 2017-10-05 | ALL UKALL2003 TRIAL | 02 | N | 210031465 | UKALL 2003 |
| 210033317 | 210011824 | 1.74 | 26.3 | Curative (C) | 2017-12-30 | 2018-01-05 | Triple Intrathecal | 2 | N | 210031507 | TRIPLE INTRATHECAL |
| 210033318 | 210011831 | 1.63 | null | Curative (C) | 2015-08-01 | 2015-11-18 | Triple / Double Intrathecal Therapy | 02 | N | 210031512 | TRIPLE INTRATHECAL |
| 210033319 | 210011832 | 1.79 | 72.8 | null | 2017-11-14 | 2018-02-01 | ALL UKALL60+ TRIAL | 02 | null | 210031516 | UKALL60+ |
| 210033320 | 210027525 | null | 65.75 | Curative (C) | 2014-03-16 | 2014-03-17 | IMATINIB | N | N | 210031542 | IMATINIB |
| 210033321 | 210027526 | 1.71 | 75.6 | Palliative (P) | 2016-11-26 | 2017-04-17 | R Chlorambucil | 02 | N | 210031543 | CHLORAMBUCIL + RITUXIMAB |
| 210033322 | 210011845 | null | 94.5 | Curative (C) | 2016-08-30 | 2016-11-07 | ALL UKALL60+ TRIAL | Y | N | 210031570 | UKALL60+ |
| 210033323 | 210011864 | 0 | 63 | Curative (C) | 2013-06-26 | 2014-01-01 | CHLORAMBUCIL + OBINUTUZUMAB | 02 | N | 210031682 | CHLORAMBUCIL + OBINUTUZUMAB |
| 210033325 | 210011874 | 1.11 | null | Curative (C) | 2018-04-07 | 2018-04-21 | IDELALISIB + RITUXIMAB | Y | N | 210031749 | IDELALISIB + RITUXIMAB |
| 210033326 | 210011886 | 1.58 | 8.9 | Curative (C) | 2014-06-07 | 2014-07-14 | ALL UKALL60+ TRIAL | N | N | 210031805 | UKALL60+ |
| 210033327 | 210011889 | 1.77 | 95.1 | Adjuvant (A) | 2016-01-05 | 2016-02-05 | Imatinib 400mg | 02 | N | 210031811 | IMATINIB |
| 210033328 | 210027547 | null | null | Curative (C) | 2016-03-31 | 2016-08-08 | ALL UKALL60+ TRIAL | 99 | null | 210031879 | UKALL60+ |
| 210033329 | 210011920 | 0 | 54.3 | Curative (C) | 2016-09-13 | 2016-10-12 | CHLORAMBUCIL + OBINUTUZUMAB | 01 | N | 210032019 | CHLORAMBUCIL + OBINUTUZUMAB |
| 210033330 | 210011925 | 1.65 | 47 | Adjuvant (A) | 2013-11-13 | 2014-02-06 | Imatinib 200mg | Y | N | 210032021 | IMATINIB |
| 210033331 | 210027556 | null | 59.8 | Disease modification (D) | 2013-12-27 | 2014-07-18 | METHOTREXATE | 1 | N | 210032022 | METHOTREXATE |
| 210033332 | 210011936 | 1.76 | 75 | Curative (C) | 2015-10-05 | 2016-01-28 | CHLORAMBUCIL + RITUXIMAB | N | N | 210032066 | CHLORAMBUCIL + RITUXIMAB |
| 210033333 | 210011973 | 1.58 | 50 | Curative (C) | 2017-03-19 | 2017-06-04 | Imatinib 600mg | N | N | 210032412 | IMATINIB |
| 210033334 | 210011985 | 1.57 | 116.5 | Curative (C) | 2013-07-09 | 2013-09-17 | CHLORAMBUCIL + OBINUTUZUMAB | Y | N | 210032491 | CHLORAMBUCIL + OBINUTUZUMAB |
| 210033335 | 210027581 | 1.75 | 56.6 | Curative (C) | 2016-11-19 | 2016-11-30 | Imatinib 400mg | N | N | 210032534 | IMATINIB |
| 210033337 | 210012006 | 1.57 | 57.3 | Curative (C) | 2018-01-08 | 2018-02-09 | ALL UKALL2003 TRIAL | 2 | N | 210032587 | UKALL 2003 |
| 210033338 | 210012011 | 1.69 | 115 | null | 2016-02-01 | 2016-07-15 | METHOTREXATE | N | N | 210032638 | METHOTREXATE |
| 210033339 | 210012019 | 1.77 | 92.5 | Curative (C) | 2014-08-03 | 2014-11-27 | IMATINIB | Y | N | 210032683 | IMATINIB |
| 210033340 | 210012031 | 1.73 | 59.4 | Curative (C) | 2014-04-25 | 2014-05-03 | ALL UKALL60+ TRIAL | N | N | 210032731 | UKALL60+ |
| 210033341 | 210012034 | 1.82 | null | Palliative (P) | 2018-07-14 | 2018-12-16 | CHLORAMBUCIL + OBINUTUZUMAB | N | null | 210032734 | CHLORAMBUCIL + OBINUTUZUMAB |
| 210033342 | 210012056 | null | null | null | 2016-08-04 | 2016-09-02 | Imatinib 400mg | N | N | 210032826 | IMATINIB |
| 210033343 | 210012060 | 1.66 | 57.8 | Curative (C) | 2013-11-18 | 2014-02-18 | Triple / Double Intrathecal Therapy | 02 | N | 210032841 | TRIPLE INTRATHECAL |
| 210033344 | 210012067 | 1.74 | 78.4 | Curative (C) | 2013-04-10 | 2013-09-09 | ALL UKALL2003 TRIAL | N | N | 210032895 | UKALL 2003 |
| 210033345 | 210021675 | 1.69 | 59.4 | Palliative (P) | 2017-06-28 | 2017-07-28 | IMATINIB | N | N | 210032935 | IMATINIB |
| 210033346 | 210012076 | 0 | 95.8 | Palliative (P) | 2016-08-19 | 2017-06-28 | IMATINIB | N | N | 210032940 | IMATINIB |
| 210033347 | 210021681 | 1.64 | 50 | Curative (C) | 2016-10-20 | 2016-10-25 | CHLORAMBUCIL + RITUXIMAB | 2 | N | 210032961 | CHLORAMBUCIL + RITUXIMAB |
| 210033348 | 210012084 | 1.79 | 82 | Palliative (P) | 2014-10-10 | 2014-10-10 | IMATINIB | N | N | 210032967 | IMATINIB |
| 210033349 | 210027619 | 1.84 | 76.5 | Disease modification (D) | 2019-02-09 | 2019-05-11 | IDELALISIB + RITUXIMAB | 2 | N | 210032998 | IDELALISIB + RITUXIMAB |